Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579156 · ClinicalTrials.gov registry record · NA
TearCare in Young Adults
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07579156 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants.
The verdict
NCT07579156, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs at Day 28.
Interventions
- DEVICE TearCare®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07579156
The ClinicalTrials.gov registry entry for NCT07579156 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TearCare® is the first listed.
NCT07579156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07579156 about?
NCT07579156 is a clinical study titled "TearCare in Young Adults". This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare® performed at Visit 1. A single follow-up examination occurs...
What is the current status of trial NCT07579156?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-08-01. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07579156?
The interventions under investigation include: TearCare® (DEVICE).
Who is sponsoring clinical trial NCT07579156?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.